MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (âSyneos Healthâ or the âCompanyâ), a leading fully integrated biopharmaceutical solutions organization, today announced that the Companyâs stockholders approved an agreement to take the Company private through an acquisition by a consortium of private investment firm affiliates…Read More
Syneos Health Stockholders Approve Agreement with Private Investment Consortium
